Recently Viewed
empty-cart

There are no Recent Items

Close
Login/Register

Close
Single User License Price USD 250
Single User License Price INR 17500
Corporate User License Price USD 750
Corporate User License Price INR 52500
Site License Price USD 500
Site License Price INR 35000
Request a Quote

Report Title

SRI International - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Quote Request for License Type
License Type Price  
Single User License USD 250
Site License USD 500
Enterprise Wide License USD 750
"Thanks for submitting the form. Our marketing team will connect back to you for the budget constraint."
Close
REQUEST A CUSTOMIZED RESEARCH

Report Title

SRI International - Pharmaceuticals & Healthcare - Deals and Alliances Profile


Quote Request for License Type
License Type Price  
Single User License USD 250
"Thanks for letting us know your requirement. Our research team will connect back to you for the bespoke requirement."
Close
REQUEST FOR SAMPLE REPORT

Report Title

SRI International - Pharmaceuticals & Healthcare - Deals and Alliances Profile

"Thanks for submitting the form. The concerned team will send the sample report in the next 12 hours."
"Thank you for downloading the sample report."
Close

SRI International - Pharmaceuticals & Healthcare - Deals and Alliances Profile



Executive Summary

Summary

SRI International (SRI) is a non-profit organization that provides commercial research and development programs. The organization's services include research and development, innovation consulting, technology solutions, bioscience contract research, specialized facilities and services. It performs research and development activities in the areas of biosciences, health and medical systems, chemistry and materials, communications and networks, computing, earth and space, economic development, education and learning, energy and green tech, security and defense, sensing, space and radar, security and defense, robotics among others. SRI's biomedical sector offers basic research on disease mechanisms, biologic drug discovery and development, nonclinical contract services, laboratory experiments, computer simulations, testing, behavioral pharmacology and other programs. The organization caters to government, corporations, commercial businesses, start up companies, industry consortiums, private foundations and venture firms. It has operations across the US. SRI is headquartered in Menlo Park, California, the US.

SRI International-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

SRI International, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

SRI International, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

SRI International, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

SRI International, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

SRI International, Medical Devices Deals, 2012 to YTD 2018 9

SRI International, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

SRI International, Pharmaceuticals & Healthcare, Deal Details 11

Partnerships 11

SRI International Enters into Reaserch Agreement with Ionis Pharma 11

ShangPharma and SRI International Enter into Drug Discovery Agreement 12

SRI Biosciences Enters into Agreement with Stanford Cancer Institute 13

SRI Biosciences Enters into Agreement with Stanford Cancer Institute 14

SRI International Enters into Contract for PREVENT Cancer Program 15

SRI International Enters into Biological Testing Facility Contract with NICHD 16

SRI International Enters into Agreement with National Institute of Allergy and Infectious Diseases 17

Sareum And SRI International Enter Into Co-Development Agreement For Autoimmune And Inflammatory Diseases 18

Inscopix Enters Into Co-Development Agreement With SRI International For nVista HD 19

Licensing Agreements 20

SRI International Enters into Licensing Agreement with Nobelpharma 20

Asset Transactions 21

Helix Twelve Pharma Acquires Rights to HLX-801 from SRI International 21

SRI International-Key Competitors 22

SRI International-Key Employees 23

SRI International-Locations And Subsidiaries 25

Head Office 25

Other Locations & Subsidiaries 25

Recent Developments 27

Product News 27

Dec 07, 2017: Scientists From SRI International and Collaborations Pharma Identify Potential New Ebola Virus Therapy 27

04/27/2017: SRI International Awarded USD 4.7 Million in Agreements to Manufacture and Test Vaccine Against Venezuelan Equine Encephalitis 28

Other Significant Developments 29

Jul 10, 2017: Thermo Fisher Scientific and SRI International Collaborate to Enhance Small Molecule Research 29

Appendix 30

Methodology 30

About GlobalData 30

Contact Us 30

Disclaimer 30

To know more information on Purchase by Section, please send a mail to sales@kenresearch.com

List of Figures

SRI International, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

SRI International, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

SRI International, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

SRI International, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

SRI International, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

SRI International, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6

SRI International, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

SRI International, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

SRI International, Medical Devices Deals, 2012 to YTD 2018 9

List of Tables

SRI International, Pharmaceuticals & Healthcare, Key Facts 2

SRI International, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5

SRI International, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6

SRI International, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7

SRI International, Deals By Therapy Area, 2012 to YTD 2018 8

SRI International, Medical Devices Deals, 2012 to YTD 2018 9

SRI International, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10

SRI International Enters into Reaserch Agreement with Ionis Pharma 11

ShangPharma and SRI International Enter into Drug Discovery Agreement 12

SRI Biosciences Enters into Agreement with Stanford Cancer Institute 13

SRI Biosciences Enters into Agreement with Stanford Cancer Institute 14

SRI International Enters into Contract for PREVENT Cancer Program 15

SRI International Enters into Biological Testing Facility Contract with NICHD 16

SRI International Enters into Agreement with National Institute of Allergy and Infectious Diseases 17

Sareum And SRI International Enter Into Co-Development Agreement For Autoimmune And Inflammatory Diseases 18

Inscopix Enters Into Co-Development Agreement With SRI International For nVista HD 19

SRI International Enters into Licensing Agreement with Nobelpharma 20

Helix Twelve Pharma Acquires Rights to HLX-801 from SRI International 21

SRI International, Key Competitors 22

SRI International, Key Employees 23

SRI International, Other Locations 25

SRI International, Subsidiaries 26

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License:
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

SRI International, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.


Related Products in vertical
red-whiteline

RECENT VIEWED REPORTS



Sign up for newsletter

Close
Apply For Job

  • Applicant Name
  • Job Function
  • Total Experience
  • Skills
  • Email ID
  • Notice Period
  • Current CTC & Expected CTC
  • Phone Number
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Your resume has been successfully received. HR will connect you within 14 days in case your resume gets shortlisted."
Close
Download Company Brochure

  • Name
  • Email
  • Company Name
  • Select Country*
  • Phone Number
  • Validation
  •   info-icon

    If validation code does not match, please refresh the page.

Close
Engage With Us

  • Name
  • Designation
  • Email
  • Phone No.
  • Company Name
  • Company URL
  • Select Country*
  • Requirements/ Comments
  • Validation
  • captcha  info-icon

    If validation code does not match, please refresh the page.

  • "Thanks for submitting the form. The concerned team will respond to your query in the next 8-12 hours"
Close

Compare

Expand

person